T. Rowe Price Associates »

Cue Biopharma shares owned by T. Rowe Price Associates

Quarter-by-quarter ownership of Cue Biopharma (CUE) shares owned by T. Rowe Price Associates from 13F filings

Historical chart of T. Rowe Price Associates investment in Cue Biopharma

Tip: Access up to 7 years of quarterly data

All positions including Cue Biopharma held by T. Rowe Price Associates consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Cue Biopharma by T. Rowe Price Associates

Quarter filed Position value Share count Share price at filing
2023-12-31 $49k 18k 2.69
2023-09-30 $39k 17k 2.34
2023-06-30 $61k 17k 3.67

More positions owned by T. Rowe Price Associates

Microsoft Corp Comm Stk (MSFT)
Apple Comm Stk (AAPL)
Amazon Comm Stk (AMZN)
Nvidia Corporation Comm Stk (NVDA)
Meta Platforms Comm Stk (META)
Alphabet Comm Stk (GOOGL)
Alphabet Comm Stk (GOOG)
Unitedhealth Group Comm Stk (UNH)
Eli Lilly & Co Comm Stk (LLY)
Visa Comm Stk (V)
Mastercard Incorporated Comm Stk (MA)
Tesla Comm Stk (TSLA)
Intuit Comm Stk (INTU)
Servicenow Comm Stk (NOW)
Fiserv Comm Stk (FI)

View all positions for T. Rowe Price Associates

Top funds holding Cue Biopharma

Vanguard Group
Bleichroeder
Robertson Stephens Wealth Management
Dimensional Fund Advisors
Monaco Asset Management SAM
Millennium Management
Bank of America Corporation
Sigma Planning
GSA Capital Partners
Stifel Financial
Charles Schwab Investment Management
Good Life Advisors
UBS Group
Bank of New York Mellon
HighTower Advisors

View all funds holding Cue Biopharma